By proceeding, you agree to our Terms of Use and Privacy Policy.
LUMICKS is the leading supplier of Dynamic Single-Molecule and Cell Avidity analysis instruments.
09-11 March 2022
The Festival of Biologics brings together pharma & biotech, academics and research institutes, together with their partners across the value chain.
Event Ended
USA
Paid
San Diego
23-25 May 2022
CHI’s Sixth Annual Immuno-Oncology Summit Europe returns to London’s Canary Wharf for three packed days of science and technology, discussion and networking, with coverage of recent advances in the development of promising immuno-oncology treatments.
Hybrid
London
27-29 June 2022
Welcome to the 3rd TCR-based Therapies for Solid Tumors Summit Advancing Engineered, Native & Bispecific TCRs to Effectively Treat Solid Tumors Do you want to gain unrivalled industry knowledge to build a first-class TCR-based therapy with high effic
Boston
19-22 September 2022
Across 3 main conference days and 8 tracks, 200+ CAR and TCR experts will lead you and your peers in discussions from novel allogeneic approaches with enhanced safety considerations, the latest in vivo gene engineering techniques, and advances in CMC
12-14 October 2022
Over the past 10 years, CHI's Immuno-Oncology Summit has become the leading annual meeting focusing on the latest applied research, providing comprehensive and in-depth coverage across all modalities and stages in the pipeline.
02-04 November 2022
Biologic drug discovery, development, manufacturing, pricing & market access, Clinical Trials. The Festival of Biologics brings together pharma & biotech, academics and research institutes, together with their partners across the value chain.
Switzerland
Basel
21-23 February 2023
Join us in London this February to connect with those trailblazing the next wave of CAR and TCR based approaches from pre-clinical development with in vivo engineering and regulatory fast-track strategies to streamlined analytics and automation to ma
UK
20-22 March 2023
28-30 March 2023
Dedicated to driving cost-effective, efficacious, safe, durable, scalable, and globally accessible allogeneic, cell-based, and engager therapies, the 8th Innate Killer Summit returns to cement your end-to-end education in innate immune therapeutics.
29-01 September 2023
The Vice President of Discovery and Translational Research at Deverra Therapeutics, Erika von Euw, highly recommends attending the upcoming CAR-TCR Summit if you work in cell therapy. Last year marked a significant milestone in the field of cell ther